Skip to main content

Table 1 Clinicopathological characteristics of gastric cancer patients

From: Prognostic value of differentiation status in gastric cancer

Characteristics

Well, n (%)

Moderately, n (%)

Poorly, n (%)

P value

Age

   

< 0.001

  ≤ 60

197(10.8)

406(22.2)

1226(67.0)

 

 >60

173(13.7)

430(34.1)

658(52.2)

 

Gender

   

< 0.001

 Male

308(12.7)

716(29.6)

1398(57.7)

 

 Female

62(9.3)

120(18.0)

486(72.7)

 

Tumor location

   

< 0.001

 Upper third

146(14.9)

351(35.7)

485(49.4)

 

 Middle third

47(9.3)

108(21.4)

350(69.3)

 

 Lower third

163(12.0)

329(24.2)

867(63.8)

 

 Cross or entire

14(5.7)

48(19.7)

182(74.6)

 

Tumor size

   

< 0.001

  ≤ 5

332(15.3)

613(28.2)

1228(56.5)

 

 >5

38(4.2)

223(24.3)

656(71.5)

 

Tumor depth

   

< 0.001

 T1

193(32.9)

165(28.2)

228(38.9)

 

 T2

49(10.1)

153(31.5)

284(58.4)

 

 T3

96(8.6)

351(31.4)

670(60.0)

 

 T4

32(3.6)

167(18.5)

702(77.9)

 

Lymph node metastasis

   

< 0.001

 N0

274(24.2)

360(31.8)

498(44.0)

 

 N1

52(8.8)

200(33.8)

340(57.4)

 

 N2

27(5.1)

142(26.8)

361(68.1)

 

 N3

17(2.0)

134(16.0)

685(82.0)

 

Tumor stage

   

< 0.001

 I

225(28.9)

241(31.0)

312(40.1)

 

 II

93(10.1)

316(34.3)

511(55.6)

 

 III

52(3.7)

279(20.1)

1061(76.2)